首页> United European gastroenterology journal> Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Nicola,Pugliese

第一单位： Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.;Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy.

作者： Nicola,Pugliese ^[1] ; Ivan,Arcari ^[1] ; Federica,Cerini ^[2] ; Rosa,Lombardi ^[3] ; Federica,Turati ^[4] ; Grazia,Pennisi ^[5] ; Matteo,Soleri ^[1] ; Simone,Rocchetto ^[2] ; Diletta,De Deo ^[1] ; Michele,Sagasta ^[6] ; Chiara,Masetti ^[1] ; Anna Ludovica,Fracanzani ^[3] ; Salvatore,Petta ^[5] ; Carlo,La Vecchia ^[4] ; Mauro,Viganò ^[7] ; Alessio,Aghemo ^[1]

作者单位： Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.;Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy. ^[1] Hepatology Unit, San Giuseppe Hospital, Milan, Italy.;Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. ^[2] Unit of Metabolic Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.;Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. ^[3] Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. ^[4] Section of Gastroenterology, PROMISE, University of Palermo, Palermo, Italy. ^[5] Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.;Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy. ^[6] Gastroenterology, Hepatology and Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy. ^[7]

关键词 GLP‐1 agonists MASLD diet exercise lifestyle modification metabolic syndrome obesity steatotic liver disease type 2 diabetes weight loss